Transense Technologies Provides Trading Update and Modest Outlook for FY27

Transense Technologies trading update: softer FY26 than hoped, but the growth story is still intact

Transense Technologies has told the market to expect FY26 revenue of not less than £4.6 million, adjusted EBITDA of not less than £0.5 million, and adjusted profit before tax of approximately break-even. In plain English, the company is still growing parts of the business and staying operationally profitable before some accounting adjustments, but it is not quite hitting the level investors were led to expect back in January.

That is the key takeaway here. This is not a blow-up, but it is a reset. The tone is cautious rather than alarmed, and the company is making it clear that timing – especially the timing of customer orders and contract sign-offs – is the main issue.

Key FY26 numbers from the Transense RNS announcement

Metric	FY26 update	Comparison / comment
Group revenue	Not less than £4.6 million	Modest reduction versus January 2026 expectations
Adjusted EBITDA	Not less than £0.5 million	Still positive at operating level
Adjusted profit before tax	Approximately break-even	Profitability remains tight
Cash at 31 May 2026	£1.12 million	Down from £1.33 million at 31 December 2025
Net cash at 31 May 2026	£0.71 million	Down from £0.92 million at 31 December 2025
SAWsense revenue	Not less than £1.3 million	Up from £1.12 million in FY25
Translogik revenue	Not less than £1.25 million	Down from £1.32 million in FY25
Bridgestone iTrack royalty income	Not less than £2.0 million	As expected, with modest growth expected in FY27

Why Transense is missing earlier expectations

Management has pointed to three main reasons for the lighter outcome. First, Translogik sales to global tyre manufacturers were lower than anticipated. Second, SAWsense development projects are progressing, but customers have been slower to commit to short-term non-recurring engineering costs – that means upfront development spend paid by customers for bespoke work.

Third, the good news is that Bridgestone iTrack royalties are performing as expected. That matters because the royalty stream looks like the most dependable part of the group right now, helping to steady the ship while the more growth-focused divisions convert pipeline into signed business.

My view is that this is a classic small-cap issue: the opportunity is there, but revenue recognition can be lumpy. When management says deals are advanced but not yet formalised, that is encouraging operationally, but investors should remember it is not cash in the bank until signatures land.

SAWsense growth is real, and that is probably the most important positive in this update

SAWsense looks like the standout division in this statement. Revenue is expected to be not less than £1.3 million, ahead of the £1.12 million reported in FY25, with continued growth driven by T901 and motorsport programmes.

There is also a wider pipeline across robotics and other target markets, with some projects moving towards production. That last bit is important because development work is useful, but the real value comes when programmes shift into repeat production revenue.

The company says the earliest production dates in this pipeline remain realistically in 2027 or 2028. That is promising, but it also underlines the patience required here. Transense is building capability and customer traction, but this is not an overnight scale-up story.

Translogik is under pressure now, but management sees a better FY27 ahead

Translogik is the softer spot. Revenue is expected to be not less than £1.25 million, slightly below the £1.32 million achieved in FY25, as reduced demand from global tyre majors held things back.

That said, management is trying to balance that disappointment with signs of commercial progress. It says the pipeline is strengthening, direct and distribution activity is increasing, and new product launches are expected to start contributing in FY27.

There is also a notable line saying several customer and partnership agreements are at an advanced stage, with terms substantially agreed and expected to conclude in the near term. If that turns into signed deals, sentiment could improve quickly. If it drifts again, investors may start to question how reliable the conversion timetable really is.

Cash, balance sheet discipline and why the £1 million headroom target matters

Cash at 31 May 2026 was £1.12 million, with net cash of £0.71 million. That is lower than at 31 December 2025, although the company says planned working capital movements in June will only temporarily reduce the year-end position and should reverse with strong cash collections in July.

That explanation is reasonable, but cash always matters more when profits are close to break-even. The board says it intends to keep gross cash headroom at around £1 million and fund working capital and product investment through adjusted EBITDA profitability and internal cash generation.

To me, that reads as disciplined but also slightly tight. There is no financing announcement here, and none is suggested, but this is not a business sitting on a huge cash buffer either. Investors should keep an eye on cash conversion in the next set of results.

Transense FY27 outlook: prudent guidance, not a confidence collapse

The board says FY27 expectations are being moderated. That is the headline investors will notice, but the wording matters. Management is not saying demand has disappeared. It is saying the timing of advanced opportunities remains uncertain, and several significant programmes are still awaiting firm contractual commitment.

That feels prudent rather than dramatic. Small technology-led businesses often get into trouble when they guide too aggressively on deals that are not yet signed, so there is something to be said for resetting expectations before year-end rather than hoping for a late rescue.

The company still believes these opportunities could materially enhance performance in FY27 and beyond. That may prove right, but for now the market is being asked to trust the pipeline again. Trust is easier to maintain when contract announcements start following the commentary.

What this Transense RNS means for retail investors

For existing shareholders, this is a mildly disappointing update wrapped around a still-interesting long-term story. FY26 is coming in a bit light, cash is fine but not abundant, and FY27 has been toned down. None of that is ideal.

On the positive side, SAWsense is growing, Bridgestone royalties remain solid, the pilot production line procurement is complete, and initial production validation and process control results are said to be as expected. That tells you the operational platform is moving forward even if the commercial conversion is slower than hoped.

So my overall read is balanced. This update is negative for short-term expectations, but not obviously damaging to the medium-term investment case. If Transense can turn its advanced discussions into signed contracts over the next few months, this RNS may end up looking like a temporary wobble rather than the start of something more serious.

Investor Meet Company seminar details for Transense shareholders

Executive Chairman Nigel Rogers will answer questions through Investor Meet Company on Tuesday 23 June at 4:30pm GMT. For retail investors, that is worth watching because this update leaves some obvious follow-up questions around deal timing, cash movements and what exactly underpins the confidence in FY27 and beyond.

Investors can register via Investor Meet Company. More company background is also available on the Transense website.